arrow
C

Corinne Haïoun

Henri Mondor University Hospital
H指数:103
被引数:3.7万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Risk stratification of diffuse large B-cell lymphoma patients using plasma NMR-based metabolomics at diagnostic

使用血浆NMR基代谢组学对弥漫性大B细胞淋巴瘤患者进行风险分层以用于诊断

2025-10-100
OAAI
Clinical benefit of tafasitamab plus lenalidomide in relapsed or refractory diffuse large B-cell lymphoma: real-world data from the EarlyMIND study

Brisou, G.; Paillassa, J.; Bernard, S.; Tournilhac, O.; Fornecker, L.M.; Maloisel, F.; Gastaud, L.; Durot, E.; Tempescul, A.; Braun, T.; 等. 塔法西单抗联合来那度胺在复发或难治性弥漫大B细胞淋巴瘤中的临床获益:EarlyMIND研究真实世界数据. Haematologica 2025, 110, 2400–2412. [Google Scholar] [CrossRef]

2025-10-010
OAAI
Impact of Body Composition on Treatment Toxicity and Outcomes in Patients With Primary Mediastinal Large B-Cell Lymphoma

身体成分对原发性纵隔大B细胞淋巴瘤患者治疗毒性和预后的影响

2025-07-110
OAAI
Efficacy of tazemetostat in combination with R-CHOP in elderly patients newly diagnosed with diffuse large B cell lymphoma: results of the EpiRCHOP phase II study of the LYSA

塔泽莫斯托stat与R-CHOP联合治疗新诊断弥漫性大B细胞淋巴瘤老年患者的疗效:LYSA的EpiRCHOP II期研究结果

2025-04-010
PRE
Analysis of peripheral neuropathy in the POLARIX study using clinician- and patient-reported outcomes

POLARIX研究中使用临床医生和患者报告结局对周围神经病变的分析

2025-03-170
OA
Cold Autoimmune Hemolytic Anemia Secondary to Mycoplasma Pneumoniae Infection in Adults: Results from a Large French Observational Study (MYCOLD study)

成人支原体肺炎感染继发性冷自身免疫性溶血性贫血:来自一项大型法国观察性研究(MYCOLD研究)的结果

BLOOD
IF23.1
2024-11-050
PRE
Real-world data for marginal zone lymphoma patients in the French REALYSA cohort: The REALMA study

法国REALYSA队列边缘区淋巴瘤患者的真实数据: REALMA研究

2024-10-010
OAAI
Identification, risk factors, and clinical course of CNS relapse in DLBCL patients across 19 prospective phase 2 and 3 trials-a LYSA and GLA/ DSHNHL collaboration
LEUKEMIA
IF13.4
2024-08-160
PRE
Epstein-Barr virus and immune status imprint the immunogenomics of non-Hodgkin lymphomas occurring in immune-suppressed environments
2024-06-061
OAAI
Cerebellum/liver index on baseline 18F-FDG PET/CT to improve prognostication in post-transplant lymphoproliferative disorders: a multicenter retrospective study

基线18F-FDG PET/CT小脑/肝脏指数改善移植后淋巴增生性疾病预后的多中心回顾性研究

2024-05-270
OAAI
IELSG38: phase II trial of front-line chlorambucil plus subcutaneous rituximab induction and maintenance in mucosa-associated lymphoid tissue lymphoma
2024-02-220
OAAI
Challenges for quality and utilization of real-world data for diffuse large B-cell lymphoma in REALYSA, a LYSA cohort
2024-01-102
OAAI
Single-agent activity of phosphatidylinositol 3-kinase inhibition with copanlisib in patients with molecularly defined relapsed or refractory diffuse large B-cell lymphoma (vol 34, pg 2184, 2020)
LEUKEMIA
IF13.4
2024-01-100
OAAI
High PDL1/PDL2 gene expression correlates with worse outcome in primary mediastinal large B-cell lymphoma
2023-12-042
OAAI
Nonrelapse mortality after CAR T-cell therapy for large B-cell lymphoma: a LYSA study from the DESCAR-T registry
2023-10-3023
OAAI
Central nervous system relapse in younger patients with diffuse large B-cell lymphoma: a LYSA and GLA/DSHNHL analysis
2023-07-285
OAAI
Baseline 18F-FDG Metabolic Tumor Volume Predicts Response to Rituximab Induction in Post-transplant Lymphoproliferative Disorders: A Multi-institutional Retrospective Study
2023-02-011
OAAI